(Q40579349)

21 September 2017

1 reference

title

Insulin and lipoprotein metabolism with special reference to the diabetic state (English)

1 reference

21 September 2017

Tomkin GH

1

1 reference

21 September 2017

Owens D

series ordinal

2

1 reference

21 September 2017

publication date

1 October 1994

1 reference

Diabetes/metabolism reviews

21 September 2017

published in

1 reference

21 September 2017

volume

10

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

225-252

1 reference

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Increased production rates of LDL are common in individuals with low plasma levels of HDL cholesterol, independent of plasma triglyceride concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Effect of insulin on low-density-lipoprotein metabolism in human lymphocytes in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Lipoprotein receptors and cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

The oxidative modification of low-density lipoproteins by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Lipoprotein[a] as a risk factor for preclinical atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin stimulation of cholesterol synthesis by arterial tissue

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Type 2 (non-insulin-dependent) diabetes mellitus and cardiovascular disease--putative association via common antecedents; further evidence from the Whitehall Study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Body fat distribution and coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes mellitus: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Possible link between a low prevalence of cardiovascular disease and mild dyslipidaemia: a study in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Banting lecture 1988. Role of insulin resistance in human disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-up

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Association of HbA1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Immunoradiometric assay of insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin deficiency and increased plasma concentration of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factors in type 2 (non-insulin-dependent) diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma insulin and serum lipids and lipoproteins in middle-aged non-insulin-dependent diabetic and non-diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma triglyceride level and mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Ten-year mortality from cardiovascular disease in relation to cholesterol level among men with and without preexisting cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The Role of Insulin Insensitivity and Hepatic Lipase in the Dyslipidaemia of Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Effect of insulin therapy on metabolic fate of apolipoprotein B-containing lipoproteins in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels. A population-based study

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin resistance, glucose intolerance, and hyperinsulinemia. Hypertriglyceridemia versus hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin resistance in familial and nonfamilial hypercholesterolemia.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition. Possible link between hyperinsulinemia and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein compositional abnormalities and insulin resistance in type II diabetic patients with mild hyperlipidemia.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Gender differences in a type 2 (non-insulin-dependent) diabetic population with respect to apolipoprotein E phenotype frequencies.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The impact of the apolipoprotein E polymorphism on the lipoprotein profile in insulin-dependent diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study IX.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Improved glycemic control lowers plasma apoprotein E and triglyceride levels following ingestion of a fat load in insulin-dependent diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Relation of coronary heart disease and apolipoprotein E phenotype in patients with non-insulin dependent diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Apolipoprotein E phenotype is related to macro- and microangiopathy in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Cholesterol absorption, elimination, and synthesis related to LDL kinetics during varying fat intake in men with different apoprotein E phenotypes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Apolipoprotein E polymorphism is associated with plasma cholesterol response in a 7-day hospitalization study for metabolic and dietary control in NIDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Contributions of Absorbed Dietary Cholesterol and Cholesterol Synthesized in Small Intestine to Hypercholesterolemia in Diabetic Rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Inhibition of acylcoenzyme A: cholesterol acyltransferase activity by PD128O42: effect on cholesterol metabolism and secretion in CaCo-2 cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Effects of the ACAT inhibitor CL 277,082 on cholesterol metabolism in humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Cholesterol metabolism in alloxan-induced diabetic rabbits

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Serum lipoproteins and cholesterol metabolism in two hypercholesterolaemic rabbit models

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Importance of small intestine in diabetic hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

De novo cholesterol synthesis in three different animal models of diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Intestinal and Hepatic Cholesterogenesis in Hypercholesterolemic Dyslipidemia of Experimental Diabetes in Dogs

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Normal plasma cholesterol in an 88-year-old man who eats 25 eggs a day. Mechanisms of adaptation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The effect of insulin and catecholamines on the activities of 3-hydroxy-3-methyl glutaryl coenzyme A reductase and acyl-coenzyme A: cholesterol-o-acyltransferase in isolated rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Abnormalities in the metabolism of postprandial and fasting triglyceride-rich lipoprotein subfractions in normal and insulin-dependent diabetic subjects: effects of sex.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hyperinsulinaemia is associated with stimulation of cholesterol synthesis in both type 1 and type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hypertriglyceridemia Associated with Deficiency of Apolipoprotein C-II

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Metabolism of HDL apolipoprotein A-I and A-II in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Body weight, skeletal muscle morphology, and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48-year-old men.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The response of hepatic lipase and serum lipoproteins to acute hyperinsulinaemia in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Effect of hepatic lipase on LDL in normal men and those with coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Low density lipoprotein receptor-related protein mediates uptake of cholesteryl esters derived from apoprotein E-enriched lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Effects of exogenous apo E-3 and of cholesterol-enriched meals on the cellular metabolism of human chylomicrons and their remnants

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Chylomicron and chylomicron remnant metabolism in STZ-induced diabetic rats

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma apolipoproteins AI, AII, B, CI, and E are glucosylated in hyperglycemic diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin regulates apolipoprotein B turnover and phosphorylation in rat hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Insulin inhibits apolipoprotein B secretion in isolated human hepatocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Physiological increments in plasma insulin concentrations have selective and different effects on synthesis of hepatic proteins in normal humans

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein lipase modulates net secretory output of apolipoprotein B in vitro. A possible pathophysiologic explanation for familial combined hyperlipidemia

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Alterations in very low density lipoprotein subfractions in normotriglyceridemic non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Abnormal distribution of VLDL subfractions in type 1 (insulin-dependent) diabetic patients: could plasma lipase activities play a role?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Metabolism by human endothelial cells of very low density lipoprotein subfractions isolated from type 1 (insulin-dependent) diabetic patients.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipolysis exposes unreactive endogenous apolipoprotein E-3 in human and rat plasma very low density lipoprotein

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Differences in lipoprotein subfraction composition and distribution between type I diabetic men and control subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The distribution profiles of very low density and low density lipoproteins in poorly-controlled male, type 2 (non-insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Abnormalities of VLDL, IDL, and LDL characterize insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Postprandial triglyceride response in type 1 (insulin-dependent) diabetes mellitus is not altered by short-term deterioration in glycaemic control or level of postprandial insulin replacement.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Low-density lipoprotein receptor activity in cultured human skin fibroblasts. Mechanism of insulin-induced stimulation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

In Vivo Stimulation of Low-Density Lipoprotein Degradation by Insulin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Modified forms of low density lipoprotein and atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Probucol reduces plasma lipid peroxides in man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Nonenzymatic glycosylation of human plasma low density lipoprotein. Evidence for in vitro and in vivo glucosylation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Non-enzymatic glycosylation of low-density lipoprotein. Results of an affinity chromatography method

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Glycated low density lipoprotein catabolism is increased in rabbits with alloxan-induced diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Genetic control of low-density-lipoprotein subclasses

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Cellular cholesterol regulation--a defect in the type 2 (non-insulin-dependent) diabetic patient in poor metabolic control

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Genetics of LDL subclass phenotypes in women twins. Concordance, heritability, and commingling analysis.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Improvement in the Regulation of Cellular Cholesterologenesis in Diabetes: the Effect of Reduction in Serum Cholesterol by Simvastatin

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The regulation of post-prandial cellular cholesterol metabolism in type 2 diabetic and non-diabetic subjects.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hypertriglyceridaemia and its Influence on Low Density Lipoprotein Regulation of Cellular Cholesterol Synthesis: a Comparison Between Hypertriglyceridaemic Diabetic and Non-diabetic Patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The effect of low density lipoprotein composition on the regulation of cellular cholesterol synthesis: a comparison in diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

A Randomized Cross-over Study of the Effects of Proinsulin on Lipid Metabolism in Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Comparison of glucosylated low density lipoprotein with methylated or cyclohexanedione-treated low density lipoprotein in the measurement of receptor-independent low density lipoprotein catabolism

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Enhanced uptake and impaired intracellular metabolism of low density lipoprotein complexed with anti-low density lipoprotein antibodies

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Stimulation of cholesteryl ester synthesis in human monocyte-derived macrophages by low-density lipoproteins from type 1 (insulin-dependent) diabetic patients: the influence of non-enzymatic glycosylation of low-density lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Metabolism of very low- and low-density lipoproteins isolated from normolipidaemic type 2 (non-insulin-dependent) diabetic patients by human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Low density lipoprotein undergoes oxidative modification in vivo

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Superoxide initiates oxidation of low density lipoprotein by human monocytes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Variations in oxidative susceptibility among six low density lipoprotein subfractions of differing density and particle size

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Free radical activity in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The oxidative modification of low density lipoprotein by nonenzymatically glycated peptide-Fe complex

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

An oxidative mechanism is involved in high glucose-induced serum protein modification causing inhibition of endothelial cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Glycosylated low density lipoprotein is more sensitive to oxidation: implications for the diabetic patient?

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Desialylated low density lipoprotein--naturally occurring modified lipoprotein with atherogenic potency

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Modified low density lipoprotein from diabetic patients causes cholesterol accumulation in human intimal aortic cells

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Autoantibodies to glucosylated proteins in the plasma of patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type I diabetic patients with human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Acid cholesteryl ester hydralase activity of mononuclear leukocytes in patients with non-insulin-dependent diabetes mellitus: studies before and after treatment of diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Advanced glycosylation end products in patients with diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein[a] concentrations and apolipoprotein[a] phenotypes in Caucasians and African Americans. The CARDIA study.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Serum lipoprotein(a) in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein(a) in diabetic patients and normoglycemic relatives in familial NIDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Apolipoprotein(a) and cardiovascular disease in Type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein (a) and Microvascular Disease in Type 1 (Insulin-dependent) Diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Serum Lp(a) lipoprotein concentrations in insulin dependent diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma apolipoprotein (a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein(a) levels in black and white children and adolescents with IDDM

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lack of change of lipoprotein (a) concentration with improved glycemic control in subjects with type II diabetes

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Improved blood glucose control by insulin therapy in type 2 diabetic patients has no effect on lipoprotein(a) levels.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

The relationship of physical fitness to lipid and lipoprotein(a) levels in adolescents with IDDM.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Acute reduction of lipoprotein(a) by tissue-type plasminogen activator

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hemobiology, vascular disease, and diabetes with special reference to impaired fibrinolysis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Hyperglycemia and plasma lipid levels: a prospective study of young insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma lipids and lipoproteins in young insulin-dependent diabetic patients: relationship with control

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipid and lipoprotein abnormalities associated with coronary heart disease in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein abnormalities in insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Downregulation of high-density lipoprotein receptor in human fibroblasts by insulin and IGF-I.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Influence of morbid obesity and non-insulin-dependent diabetes mellitus on high-density lipoprotein composition and subpopulation distribution

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Lipoprotein abnormalities in well-treated type II diabetic patients

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Reduced plasma high density lipoprotein-cholesterol concentrations need not increase when hyperglycemia is controlled with insulin in noninsulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Elevated cholesteryl ester transfer protein activity in IDDM men who smoke. Possible factor for unfavorable lipoprotein profile

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoproteins

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased cholesterylester transfer activity in complicated type 1 (insulin-dependent) diabetes mellitus--its relationship with serum lipids

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Altered regulation of cholesterol metabolism in type I diabetic women during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased transfer of cholesteryl esters from high density lipoproteins to low density and very low density lipoproteins in patients with angiographic evidence of coronary artery disease

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Increased free cholesterol in plasma low and very low density lipoproteins in non-insulin-dependent diabetes mellitus: its role in the inhibition of cholesteryl ester transfer

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Accelerated cholesteryl ester transfer in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FDMR.5610100303

7 January 2021

Identifiers

DOI

10.1002/DMR.5610100303

1 reference

21 September 2017

1 reference